EN
CN
Hwasun 
a high-tech pharmaceutical enterprise integrated of R&D, production and sales.

Hwasun has four workshops and eight production lines for API and formulation products, and has the advantage of Proton Pump Inhibitor API and sustained-release formulation. Main products have been distributed worldwide including EU and Japan. A CEP certificate was granted for Lansoprazole.



LEARN MORE
  • 15M+
    Cream/Ointment Capacity
  • 150 tons+
    API Capacity
  • 500M+
    Tablet/Capsule Capacity
  • 4
    Workshops
  • 8
    Production Lines
Product
01 / 01
  • Research and development

    We keep close cooperation with leading universities and CRO companies. With a group of well-qualified technical talents, we develop new products and optimize existing products, and provide sustainable motivation for the company.

    R&D Orientation

    We focus on developing generic API and sustained-release formulation.

    LEARN MORE
News Info
  • CompanyNews
  • IndustryTrends
  • ExchangeCooperation
  • MediaCenter
  • Links
    日本高清视频色wwwwww色